Olmesartan medoxomil impurity I Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Olmesartan medoxomil impurity I is Pale Yellow Solid

Verwenden

Olmesartan medoxomil impurity I is an intermediate used in the process for purifying Olmesartan Medoxomil.

Olmesartan medoxomil impurity I Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Olmesartan medoxomil impurity I Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	16314854226; +16314854226	inquiry@bocsci.com	United States	19741	58
career henan chemical co	+86-0371-86658258 +8613203830695	sales@coreychem.com	China	29879	58
Hubei Jusheng Technology Co.,Ltd.	18871490254	linda@hubeijusheng.com	CHINA	28172	58
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
Chongqing Chemdad Co., Ltd	+86-023-6139-8061 +86-86-13650506873	sales@chemdad.com	China	39894	58
ANHUI WITOP BIOTECH CO., LTD	+8615255079626	eric@witopchemical.com	China	23541	58
AFINE CHEMICALS LIMITED	+86-0571-85134551	sales@afinechem.com	China	15352	58
CR Corporation Limited	+8613062833949	fred.wen@crcorporation.cn	China	8647	58
Hangzhou Huarong Pharm Co., Ltd.	571-86758373 +8613588754946	sales@huarongpharm.com	CHINA	3148	58
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12373	58

879562-26-2()Verwandte Suche:

---

• (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate
• 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl]-
• 4-(1-methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methy
• Olmesartan Medoxomil Dehydro
• Olmesartan Medoxomil EP Impurity C
• Olmesartan Medoxomil EP Impurity C (Dehydro Impurity), RNH-6373
• 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methylester
• OlMesartan MedoxoMil IMpurity C (Dehydro IMpurity)
• OlMesartan EP IMp C (Dehydro OlMesartanMedoxoMil) (OlMesartan Styrene) (OlMesartenOlefin)
• OlMesartan EP IMpurity C
• (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl] -4-yl)methyl)-4-
• OlMesartan MedoxoMil iMpurity I
• Olmesartan medoxomil impurity Ⅰ
• Olmesartan impuirty C
• Olmesartan Medoxomil Impurity D(Olmesartan Medoxomil EP Impurity C)
• Olmesartan Medoxomil Impurity D
• Olmesartan Impurity 3(Olmesartan Medoxomil EP Impurity C)
• Olmesartan Medoxomil Impurity RNH-6270（4-（1-hydroxy-1-methylethyl）-2-propyl-1-[[2’-（1H-tetrazol-5-yl）biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylic acid）
• 1H-Imidazole-5-carboxylic acid, 4-(1-methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
• (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(pro
• Olmesartan EP Impurity C/ Olmesartan Medoxomil Olefinic Impurity USP (Dehydro Olmesartan Medoxomil/ Anhydro Olmesartan Medoxomil)
• 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-...
• Azilsartan medoxomil impurity239
• Olmesartan Medoxomil-3
• DES(1-hydroxy-1-methylethyl)-(1-methylethenyl)-olmesartan medoxomil
• (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-prop-1-en-2-yl-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
• Olmesartan Medoxomil impurity 12/Olmesartan Medoxomil EP Impurity C/Dehydro Olmesartan Medoxomil/(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2-(2H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate
• Olmesartan Medoxomil Impurity C
• (5-METHYL-2-OXO-1,3-DIOXOL-4-YL)METHYL 1-((2-(2H-TETRAZOL-5-YL)-[1,1-BIPHENYL]-4-YL)METHYL)-4-(PROP-1-EN-2-YL)-2-PROPYL-1H-IMIDAZOLE-5-CARBOXYLATE
• Olmesartan Medoxomil EP Impurity C, RNH-6373
• Olmesartan Medoxomilum EP Impurity C
• (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-[[2’-(5-Tetrazolyl)-4-biphenylyl]methyl]-4-(1-propen-2-yl)-2-propylimidazole-5-carboxylate
• Olmesartan EP imp C
• Anhydro Olmesartan Medoxomil
• (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl) -[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidaze -5-carboxylate
• 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
• (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate
• Olmesartan EP Impurity C Dehydro Olmesartan Medoxomil
• Olmesartan Medoxomil Olefinic Impurity (USP)
• Olmesartan ester impurity C
• (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-Methylethenyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)bipheny
• 879562-26-2
• Aromatics
• Bases & Related Reagents
• Heterocycles
• Intermediates
• Intermediates & Fine Chemicals
• Nucleotides
• Pharmaceuticals